Inherited neuropathies

Neurologic Clinics

Volumn 20, Issue 3, 2002, Pages 679-709

  Kleopa, Kleopas A ^a   Scherer, Steven S ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC DISORDER; GENETIC LINKAGE; HUMAN; NERVE FIBER DEGENERATION; NEUROPATHY; PRIORITY JOURNAL; REVIEW;

DEMYELINATING DISEASES; DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PHENOTYPE; RETROGRADE DEGENERATION;

EID: 0036699087     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8619(01)00016-0     Document Type: Review

References (170)

1. Adlkofer K, Frei R, Neuberg DH-H, et al. Heterozygous peripheral myelin protein 22-defi cient mice are affected by a progressive demyelinating peripheral neuropathy. J Neurosci 1997;17:4662-71.
2. Adlkofer K, Martini R, Aguzzi A, et al. Hypermyelination and demyelinating peripheral neuropathy in pmp22-deficient mice. Nat Genet 1995;11:274-80.
3. Anzini P, Neuberg DH-H, Schachner M, et al. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32. J Neurosci 1997;17:4545-61.
4. Arroyo EJ, Scherer SS. On the molecular architecture of myelinated fibers. Histochem Cell Biol 2000;113:1-8.
5. Auer-Grumbach M, De Jonge P, Wagner K, et al. Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology 2000;55:1552-7.
6. Auer-Grumbach M, Wagner K, Timmerman V, et al. Ulcero-mutilating neuropathy in an Austrian kinship without linage to hereditary motor and sensory neuropathy IIB and hereditary sensory neuropathy I loci. Neurology 2000;54:45-52.
7. Balice-Gordon RJ, Bone LJ, Scherer SS. Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 1998;142:1095-1104.
8. Ben Othmane K, Hentati F, Lennon F, et al. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum Molec Genet 1993;2:1625-8.
9. Ben Othmane K, Johnson E, Menold M, et al. Identification of a new locus for autosomal recessive Charcot-Marie-Tooth disease with focally folded myelin on chromosome 11p15. Genomics 1999;62:344-9.
10. Ben Othmane K, Loeb D, Hayworth-Hodgte R, et al. Physical and genetic mapping of the CMT4A locus and exclusion of PMP-22 as a defect in CMT4A. Genomics 1995;28:286-90.
11. Ben Othmane K, Middleton LT, Lopest LJ, et al. Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1993;17:370-5.
12. Benstead T, Kuntz N, Miller R, et al. The electrophysiologic profile of Dejerine-Sottas disease (HSMN III). Muscle Nerve 1990;13:586-92.
13. Bird TD, Kraft GH, Lipe HP, et al. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: A 20-year study. Ann Neurol 1997;41:463-9.
14. Birouk N, Gouider R, Le Guern E, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication - Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997;120:813-23.
15. Birouk N, Le Guern E, Maisonobe T, et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations - clinical and electrophysiological study. Neurology 1998;50:1074-82.
16. Boerkoel C, Takashima H, Bacino CA, et al. EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics 2001;3:153-7.
17. Boerkoel CF, Takashima H, Stankiexicz P, et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 2000;68:325-33.
18. Bolino A, Brancolini V, Bono F, et al. Localization of a gene responsible for autosomal recessive demyelinating neuropathy with focally folded myelin sheaths to chromosome 11q23 by homozygosity mapping and haplotype sharing. Hum Mol Genet 1996;5:1051-4.
19. Bolino A, Muglia M, Conforti FL, et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 2000;25:17-9.
20. Bomont P, Cavalier L, Blondeau F, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000;26:370-4.
21. Bone LJ, Deschênes SM, Balice-Gordon RJ, et al. Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis 1997;4:221-30.
22. Bort S, Nelis E, Timmerman V, et al. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 1997;99:746-54.
23. Bouhouche A, Benomar A, Birouk N, et al. A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2q21.3. Am J Hum Genet 1999;65:722-7.
24. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996;238:1-27.
25. Castro C, Gomez-Hernandez JM, Silander K, et al. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J Neurosci 1999;19:3752-60.
26. Chance PF, Matsunami N, Lensch W, et al. Analysis of the DNA duplication 17p11.2 in Charcot-Marie-Tooth neuropathy type-1 pedigrees - additional evidence for a third autosomal CMT1 locus. Neurology 1992;42:2037-41.
27. Chapon F, Latour P, Diraison P, et al. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J Neurol Neurosurg Psychiatry 1999;66:779-82.
28. De Jonghe P, Mersivanova I, Nelis E, et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann Neurol 2001;49:245-9.
29. De Jonghe P, Timmerman V, Ceuterick C, et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999;122:281-90.
30. De Jonghe P, Timmerman V, FitzPatrick D, et al. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J Neurol Neurosurg Psychiatry 1997;62:570-3.
31. DeJonghe P, Timmerman V, Nelis E, et al. A novel type of hereditary motor and sensory neuropathy characterized by a mild phenotype. Arch Neurol 1999;56:1283-8.
32. Delague V, Bareil C, Tuffery S, et al, Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: Exclusion of MAG as a candidate gene. Am J Hum Genet 2000;67:236-43.
33. Deschênes SM, Walcott JL, Wexler TL, et al. Altered trafficking of mutant connexin32. J Neurosci 1997;17:9077-84.
34. 0 interacts with negatively charged phospholipid bilayers. J Biol Chem 1995;269:10764-70.
35. Donaghy M, Sisodiya SM, Kennett R, et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 2000;69:799-805.
36. D'Urso D, Ehrhardt P, Muller HW. Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin. J Neurosci 1999;19:3396-403.
37. D'Urso D, Prior R, Greiner-Petter R, et al. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 1998;18:731-40.
38. rd edition. Philadelphia: WB Saunders; 1993. p. 1065-93.
39. rd edition. Philadelphia: WB Saunders; 1993. p. 1094-1136.
40. Dyck PJ, Karnes JL, Lambert EH. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989;39:1302-8.
41. Dyck PJ, Lais AC, Offord KP. The nature of myelinated nerve fiber degeneration in dominately inherited hypertrophic neuropathy. Mayo Clin Proc 1974;49:34-9.
42. Elliot JL, Kwon JM, Goodfellow PJ, et al. Hereditary motor and sensory neuropathy IIB: clinical and electrophysiological characteristics. Neurology 1997;48:23-8.
43. Fabrizi G, Cavallaro T, Simonati A, et al. Divergent phenotypes associated with missense mutations of PMP22. J Periph Nervous System 1999;4:288-9.
44. Fabrizi GM, Simonati A, Morbin M, et al. Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: A cross-sectional morphometric and immunohistochemical study in twenty cases. Muscle Nerve 1998;21:869-77.
45. Filbin MT, Tennekoon GI. Homophilic adhesion of the myelin Po protein requires glycosylation of both molecules in the homophilic pair. J Cell Biol 1993;122:451-9.
46. Filbin MT, Walsh FS, Trapp BD, et al. Role of Po protein as a homophilic adhesion molecule. Nature 1990;344:871-2.
47. Frei R, Motzing S, Kinkelin I, et al. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J Neurosci 1999;19:6058-67.
48. Gabreels-Festen AAWM, Bolhuis PA, Hoogendijk JE, et al. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 1995;90:645-9.
49. Gabreels-Festen AAWM, Gabreels FJM, Jennekens FGI, et al. Autosomal recessive form of hereditary motor and sensory neuropathy type-I. Neurology 1992;42:1755-61.
50. Gabreels-Festen AAWM, Joosten EMG, Gabreels FJM, et al. Hereditary motor and sensory neuropathy of neuronal type with onset in early childhood. Brain 1991;114:1855-70.
51. Gabreels-Festen AAWM, Joosten EMG, Gabreels FJM, et al. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN Type-I). J Neurol Sci 1992;107:145-54.
52. Garcia CA, Malamut RE, Englnad JD, et al. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995;45:2090-3.
53. Gemignani F. AM: Charcot-Marie-Tooth disease (CMT): distinctive phenotypic and genotypic features in CMT type 2. J Neurol Sci 2001;184:1-9.
54. O gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 1992;71:565-76.
55. Gouider R, LeGuern E, Gugenheim M, et al. Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology 1995;45:2018-23.
56. rd edition. (vol 1). Philadelphia: WB Saunders; 1993. p. 361-376.
57. Guilbot A, Kessali M, Ravise N, et al. The autosomal recessive form of CMT disease linked to 5q31-q33. Ann N Y Acad Sci 1999;883:56-9.
58. Guilbot A, Williams A, Ravise N, et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001;10:415-21.
59. Gutierrez A, England JD, Sumner AJ, et al. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve 2000;23:182-8.
60. Guzzetta F, Ferriere G, Lyon G. Congenital demyelinating neuropathy. Pathological findings compared with polyneuropathies starting later in life. Brain 1982;105:395-416.
61. Hahn A, Ainsworth PJ, Bolton CF, et al. Pathological findings in the X-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol 2001;101:129-39.
62. Hahn AF, Ainsworth PJ, Naus CC, Mao J, Bolton CF. Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 2000; Suppl 9:S39-49.
63. Hanemann CO, DUrso D, GabreelsFesten AAWM, et al. Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A. Brain 2000;123:1001-6.
64. Hanemann CO, Gabreels-Festen AAWM, Stoll G, et al. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs. Acta Neuropathol 1997;94:310-5.
65. Harding AE. From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 1995;118:809-18.
66. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-80.
67. Herringham WP. Muscular atrophy of the peroneal type affecting many members of a family. Brain 1889;11:230-6.
68. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 1998;279:519-26.
69. Hoogendijk JE, de Visser M, Bolhuis PA, et al. Hereditary motor and sensory neuropathy type I - clinical and neurographical features of the 17p duplication subtype. Muscle Nerve 1994;17:85-90.
70. Indo Y, Tsuruta M, Hayashida Y, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 1996;13:485-8.
71. Ionasescu V, Ionasescu R, Searby C. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am J Med Genet 1996;63:486-91.
72. Ionasescu V, Searby C, Sheffield VC, et al. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet 1996;5:1373-5.
73. Ionasescu VV, Ionasescu R, Searby C. Screening of dominantly inherited Charcot-Marie-Tooth neuropathies. Muscle Nerve 1993;16:1232-8.
74. Ismailov S, VP F, EL D, et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur J Hum Genet 2001;9:646-50.
75. Kaku DA, Parry GJ, Malamut R, et al. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 1993;43:1806-8.
76. Kaku DA, Parry GJ, Malamut R, et al. Uniform slowing of conduction velocities in Charcot-Marie-Tooth disease polyneuropathy type 1. Neurology 1993;43:2664-7.
77. Kalaydjieva L, Gresham D, Gooding R, et al. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy Lom. Am J Hum Genet 2000;67:47-58.
78. Kalaydjieva L, Hallmayer J, Chandler D, et al. Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet 1996;14:214-7.
79. Kalaydjieva L, Nikolova A, Turnev I, et al. Hereditary motor and sensory neuropathy LOM, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings. Brain 1998;121:399-408.
80. Kennerson ML, Zhu D, Gardner RJ, Storey E, Merory J, Robertson SP, et al. Dominate intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. Am J Hum Genet 2001;69:883-8.
81. Killian JM, Tiwari PS, Jacobson S, et al. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996;19:74-8.
82. Kim PS, Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocrin Rev 1998;19:173-202.
83. Korinthenberg R, Sauer M, Ketelsen UP, et al. Congenital axonal neuropathy caused by deletions in the spinal muscular atrophy region. Ann Neurol 1997;42:364-8.
84. Krajewski KM, Lewis RA, Fuerst DR, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease. Brain 2000;123:1516-27.
85. Kwon JM, Elliot JL, Yee W-c, et al. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 1995;57:853-8.
86. Lagueny A, Latour P, Vital G, et al. Mild recurrent neuropathy in CMT1B with a novel nonsense mutation in the extracellular domain of the MPZ gene. J Neurol Neurosurg Psychiatry 2001;70:232-5.
87. Le Guern E, Guilbot A, Kessali M, et al. Homozygosity mapping of an autosomal recessive form of demyelinating Charcot-Marie-Tooth disease to chromosome 5q23-q33. Hum Mol Genet 1996;5:1685-8.
88. Leal A, Morera B, DelValle G, et al. A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3. Am J Hum Genet 2001;68:269-74.
89. Lee MK, Marzalek JR, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994;13:975-88.
90. Lewis RA, Sumner AJ, Shy ME. Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve 2000;23:1472-87.
91. Lin GS, Glass JD, Shumas S, et al. A unique mutation in connexin32 associated with severe, early onset CMTX in a heterozygous female. Ann N Y Acad Sci 1999;883:481-5.
92. Lupski J, Garcia C. Charcot-Marie-Tooth peripheral neuropathies and related disorders. In: Scriver C, Beaudet A, Sly W, et al. editors. The metabolic and molecular bases of inherited disease. 8th edition, Vol IV. New York: McGraw-Hill; 2001. p. 5759-88.
93. Lupski JR. Recessive Charcot-Marie-Tooth disease. Ann Neurol 2000;47:6-8.
94. Marrosu MG, Vaccargiu S, Marrosu G, et al. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998;50:1397-401.
95. Martini R. Animal models for inherited peripheral neuropathies. J Anat 1997;191:321-36.
96. Martini R, Mohajeri MH, Kasper S, et al. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 1995;15:4488-95.
97. Martini R, Zielasek J, Toyka KV, et al. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995;11:281-5.
98. Meretoja P, Silander K, Kalimo H, et al. Epidemiology of hereditary neuropathy with liability to pressure palsies (HNPP) in southwestern Finland. Neuromusc Disord 1997;7:529-32.
99. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000;67:37-46.
100. Misu K, Yoshihara T, Shikama Y, et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene ('Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry 2000;69:806-11.
101. Mouton P, Tardieu S, Gouider R, et al. Spectrum of clinical and electrophysiological features in HNPP patients with the 17p11.2 deletion. Neurology 1999;52:1440-6.
102. Naef R, Adlkofer K, Lescher B, et al. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 1997;9:13-25.
103. Naef R, Suter U. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Dis 1999;6:1-4.
104. Nagamatsu M, Jenkins RB, Schaid DJ, et al. Hereditary motor and sensory neuropathy type 2C is genetically distinct from types 2B and 2D. Arch Neurol 2000;57:669-72.
105. Nagarajan R, Svaren J, Le N, et al. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 2001;30:355-68.
106. nd edition. Oxford: Oxford University Press; 2001. p. 177-208.
107. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 1993;43:2558-64.
108. Nicholson GA, Yeung L, Corbett A. Efficient neurophysiological selection of X-linked Charcot-Marie-Tooth families. Neurology 1998;51:1412-6.
109. Notterpek L, Shooter EM, Snipes GJ. Upregulation of the endosomal-lysosomal pathway in the Trembler-J neuropathy. J Neurosci 1997;17:4190-200.
110. Numakura C, Lin CQ, Oka N, et al. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1. Ann Neurol 2000;47:101-3.
111. Ohara O, Gahara Y, Miyake T, et al. Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J Cell Biol 1993;121:387-95.
112. Ouvrier R. Correlation between the histopathologic, genotypic, and phenotypic features of hereditary peripheral neuropathies in childhood. J Child Neurol 1996;11:133-46.
113. Ouvrier RA, McLeod JG, Conchin TE. The hypertrophic forms of hereditary motor and sensory neuropathy. A study of hypertrophic Charcot-Marie-Tooth disease (HMSN type I) and Dejerine-Sottas disease (HMSN type III) in childhood. Brain 1987;110:121-48.
114. Ouvrier RA, McLeod JG, Morgan GJ, et al. Hereditary motor and sensory neuropathy of neuronal type with onset in early childhood. J Neurol Sci 1981;51:181-97.
115. Ouvrier RA, McLeod JG, Pollard JD. Peripheral neuropathy in childhood. New York: Raven Press; 1990.
116. Pareyson D, Scaioli V, Taroni F, et al. Phenotypic heterogeneity in hereditary neuropathy with liability to pressure palsies associated with chromosome 17p11.2-12 deletion. Neurology 1996;46:1133-7.
117. Parman Y, PlanteBordeneuve V, GuiochonMantel A, et al: Recessive inheritance of a new point mutation of the PMP22 gene in Dejerine-Sottas disease. Ann Neurol 1999;45:518-22.
118. Quattrone A, Gambardella A, Bono F, et al. Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. Neurology 1996;46:1318-24.
119. Ritchie JM. Physiology of axons. In: Waxman SG, Kocsis JD, Stys PK, editors. The axon. New York: Oxford University Press; 1995. p. 68-96.
120. Roa BB, Garcia CA, Pentai L, et al. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type IA. Nat Genet 1993;5:189-94.
121. Roa BB, Garcia CA, Suter U, et al. Charcot-Marie-Tooth disease Type-1A - association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 1993;329:96-101.
122. Rogers T, Chandler D, Angelicheva D, et al. A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. Am J Hum Genet 2000;67:664-71.
123. Sahenk Z, Chen L, Freimer M. A novel PMP22 point mutation causing HNPP phenotype: Studies on nerve xenografts. Neurology 1998;51:702-7.
124. Saito M, Hayashi Y, Suzuki T, et al. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 1997;49:1630-5.
125. Sancho S, Magyar JP, Aguzzi A, et al. Distal axonopathy in peripheral nerves of PMP22 mutant mice. Brain 1999 Aug;122: Pt 8:1563-77.
126. Sander S, Nicholson GA, Ouvrier RA, et al. Charcot-Marie-Tooth disease: histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1). Muscle Nerve 1998;21:217-25.
127. Schenone A, Nobbio L, Mandich P, et al. Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies. Neurology 1997;48:445-9.
128. Scherer SS, Bone LJ, Deschênes SM, et al. The role of the gap junction protein connexin32 in the myelin sheath. In Devon RM, Doucette R, Juurlink BHJ, et al (eds): Cell Biology and Pathology of Myelin: Evolving Biological Concepts and Therapeutic Approaches. New York, Plenum Press, 1997, pp 83-102.
129. Scherer SS, Salzer JL. Axon-Schwann cell interactions in peripheral nerve regeneration. In: Jessen KR, Richardson WD, editors. Glial cell development. Oxford: Oxford University Press; 2001. p. 299-330.
130. Scherer SS, Xu Y-T, Nelles E, et al. Connexin32-null mice develop a demyelinating peripheral neuropathy. Glia 1998;24:8-20.
131. Seeman P, Huehne K, Rautenstrauss B, et al. An axonal form of Charcot-Marie-Tooth disease beginning with deafness and abnormal pupillar reaction: new mutation in the myelin protein zero gene (MPZ) in three generations of a Czech family. Nervenheilkunde 2001;20:S28.
132. Sellman MS, Mayer RF. Conduction block in hereditary neuropathies with susceptibility to pressure palsies. Muscle Nerve 1987;10:621-5.
133. Senderek J, Hermanns B, Lehmann U, et al. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: Two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol 2000;10:235-48.
134. Sereda M, Griffiths I, Puhlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996;16:1049-60.
135. Sghirlanzoni A, Pareyson D, Balestrini M, et al. HSMN III phenotype due to homozygous expression of a dominant HSMN II gene. Neurology 1992;42:2201-3.
136. 0, the major structural protein of peripheral nerve myelin. Neuron 1996;17:435-49.
137. Sherman DL, Fabrizi C, Gillespie CS, et al. Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron 2001;30:677-87.
138. 0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP). J Neuropathol Exp Neurol 1997;56:811-21.
139. Snider WD. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994;77:627-38.
140. Stojkovic T, Latour P, Vandenberghe A, et al. Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutations (R142Q). Neurology 1999;52:1010-4.
141. Street V, Goldy JD, Golden AS, et al. Mapping of Charcot-Marie-Tooth disease type 1C to chromosome 16p identifies a novel locus for demyelinating neuropathies. Am J Hum Genet 2002;70:244-50.
142. Suter U, Snipes GJ. Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 1995;18:45-75.
143. Tabaraud F, Lagrange E, Sindou P, et al. Demyelinating X-linked Charcot-Marie-Tooth disease: Unusual electrophysiological findings. Muscle Nerve 1999;22:1442-7.
144. Tachi N, Ishikawa Y, Minami R. Two cases of congenital hypomyelinating neuropathy. Brain Dev 1984;6:560-5.
145. Takashima H, Nakagawa M, Nakahara K, et al. A new type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann Neurol 1997;41:771-80.
146. Takashima H, Nakagawa M, Suehara M, et al. Gene for hereditary motor and sensory neuropathy (Proximal dominant form) mapped to 3q13.1. Neuromusc Disord 1999;9:368-71.
147. Thomas PK, Marques W, Davis MB, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997;120:465-78.
148. Timmerman V, Dejonghe P, Spoelders P, et al. Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type 2 families with chromosomes 1p35-p36 and Xq13. Neurology 1996;46:1311-8.
149. Tobler AR, Notterpek L, Naef R, et al. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci 1999;19:2027-36.
150. Topilko P, Meijer D. Transcription factors that control Schwann cell development and myelination. In: Jessen K, Richardson W, editors. Glial cell development. 2nd edition. Oxford: Oxford University Press; 2001. p. 233-44.
151. Tyson J, Malcolm S, Thomas PK, et al. Deletions of chromosome 17p11.2 in multifocal neuropathies. Ann Neurol 1996;39:180-6.
152. Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease Type-1A. Nat Genet 1992;2:288-91.
153. Vallat JM, Sindou P, Preux PM, et al. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 1996;39:813-7.
154. Vance JM, Speer MC, Stajich JM, et al. Misclassification and linkage of hereditary sensory and autonomic neuropathy type 1 as Charcot-Marie-Tooth disease, type 2B. Am J Hum Genet 1996;59:258-60.
155. VanSlyke JK, Deschênes SM, Musil LS. Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins. Mol Biol Cell 2000;11:1933-46.
156. Vedanarayanan VV, Smith S, Subramony SH, et al. Lethal neonatal autosomal recessive axonal sensorimotor polyneuropathy. Muscle Nerve 1998;21:1473-7.
157. Verhoeven K. M. V, A. R, et al: Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1. Am J Hum Genet 2001;69:889-94.
158. Villanova M. V. T, P. DJ, et al. Charcot-Marie-Tooth disease: an intermediate form. Neuromusc Disord 1998;8:392-3.
159. 0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron 1996;17:451-60.
160. Warner LE, Mancias P, Butler IJ, et al. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 1998;18:382-4.
161. Warner LE, Svaren J, Milbrandt J, et al. Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet 1999;8:1245-51.
162. Wilmshurst JM, Bye A, Rittey C, et al. Severe infantile axonal neuropathy with respiratory failure. Muscle Nerve 2001;24:760-8.
163. rd edition. Philadelphia: WB Saunders; 1993. p. 1137-48.
164. 0 protein truncated in its cytoplasmic domain. J Cell Biol 1996;134:1531-41.
165. nd edition. Oxford: Oxford University Press; 2001. p. 331-54.
166. Xu Y, Sladky JT, Brown MJ. Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication. Neurology 1989;39:1077-83.
167. Young P, Grote K, Kuhlenbaumer G, et al. Mutation analysis in Charcot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity. J Neurol 2001;248:410-5.
168. Zhang K, Filbin MT. Myelin P0 protein mutated at Cys21 has a dominant-negative effect on adhesion of wild type Po. J Neurosci Res 1998;53:1-6.
169. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bβ. Cell 2001;105:587-97.
170. 0 gene mutations. Muscle Nerve 1996;19:946-52.